Bionano Genomics, Inc. (BNGO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	S-1/A
Assets
Current assets:
Cash and cash equivalents	5.1	24.6	38.4	17.3	16.5	1.0
Investments	108.1	226.0
Accounts receivable, net	7.0	4.9	2.8	6.3	4.5	3.4
Inventory	29.8	12.4	3.3	3.4	1.1	1.7
Prepaid expenses and other current assets	9.7	5.9	2.7	1.6	0.9	1.1
Total current assets	157.3	272.4	46.8	28.3	23.0	7.1
Restricted cash	0.4
Property and equipment, net	18.0	10.3	4.9	1.9	1.8	3.0
Operating lease right-of-use assets	7.2	6.7
Intangible assets, net	41.1	26.8	1.5
Goodwill	77.3	56.2	7.2
Other long-term assets	2.4	0.7	0.1
Total assets	307.5	377.1	60.5	30.2	24.8	10.1

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	12.5	10.8	2.9	2.7	1.4	2.3
Accrued expenses	17.2	8.6	5.6	3.2	2.9	3.5
Operating lease liability	2.3	1.5
Contingent consideration	9.4
Total current liabilities	35.9	21.8	8.9	26.4	4.5	16.7
Operating lease liability, net of current portion	5.5	5.3
Contingent consideration, net of current portion	13.0	9.1
Total liabilities	58.1	40.0	25.4	26.6	14.7	17.4

Commitments and contingencies (Note 6)
Stockholders’ equity:
Common stock	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	599.2	553.7	178.7	106.2	82.9	4.0
Accumulated deficit	-348.7	-216.1	-143.7	-102.6	-72.8	-54.3
Accumulated other comprehensive loss	-1.1	-0.5
Total stockholders’ equity	249.4	337.1	35.1	3.6	10.1	-50.2
Total liabilities and stockholders’ equity	307.5	377.1	60.5	30.2	24.8	10.1